Business Bioton boost 23 May 2005 It raised its net profit prognosis for this year by zł.7 million to zł.35 million. Company president Adam Wilczęga believes that Bioton will also increase its market share to 25% of the insulin market by the end of the year. More from Business All Yesterday 88.3% of Poles choose products from promotional flyers when shopping 2 days ago Poland prepares major highway upgrades as congestion grows 2 days ago Paid DataWalk secures U.S. patent protection for AI technology
